Canada markets closed

DiaMedica Therapeutics Inc. (DMAC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.85+0.35 (+5.38%)
At close: 4:00PM EDT

6.85 0.00 (0.00%)
After hours: 5:40PM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close6.50
Open7.04
Bid6.68 x 1300
Ask6.85 x 1000
Day's Range6.76 - 7.20
52 Week Range3.77 - 10.88
Volume314,197
Avg. Volume118,250
Market Cap128.685M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.79
Earnings DateAug. 09, 2021 - Aug. 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.33
  • DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke
    Business Wire

    DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical Company focused on developing novel treatments for neurological disorders and kidney diseases, announced today that the U.S. Food & Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) application. The Company plans to proceed with a pivotal Phase 2/3 study of DM199 (recombinant human tissue kallikrein-1or KLK1) for the treatment of patients with Acute Ischemic Stroke (AIS).

  • ACCESSWIRE

    DiaMedica Therapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 6, 2021 / DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 8:00 AM Eastern Time.

  • DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
    Business Wire

    DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2021. DiaMedica will host a conference call Thursday, May 6, 2021, at 7:00 a.m. Central Time to discuss its business update and first quarter financial results.